Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Articles

Alexandra Guadagno
The combination regimen demonstrated improved efficacy outcomes with a tolerable profile among patients with relapsed/refractory mantle cell lymphoma.
Jessica Skarzynski
In patients with mantle cell lymphoma, the introduction of BTK inhibitors continues to shape the treatment landscape.
 
Alexandra Guadagno
From 240 million-year-old dinosaur tumors to today's top performers and athletes, here is a quick overview of what is making headlines in the cancer space.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to Keytruda (pembrolizumab) in combination with Inlyta (axitinib) as a frontline treatment for advanced renal cell carcinoma.
Jessica Skarzynski
One expert weighs in on the use of new immunotherapy agents and combinations in treating non-small cell lung cancer.
Joanne Lam
When Joanne Lam was diagnosed with bladder cancer, her husband showed unwavering devotion in caring for her. Now it's her turn to be his caregiver.
Kristie L. Kahl
An integrative model helped to determine which patients with bladder cancer may benefit from checkpoint inhibitor therapy.
Brielle Benyon
The Food and Drug Administration (FDA) approved a split-dosing regimen for Darzalex (daratumumab) for the treatment of patients with multiple myeloma.
Cora Fahy
A mastectomy can leave a lasting mark. This breast cancer survivor found her own unique way to make it a beautiful one.
Kristie L. Kahl
CURE® spoke with CEO Linda Tantawi about addressing the needs of underserved communities and how education is key in helping women in the Greater New York City area.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other